PubRank

Ian G McKeith

Author PubWeight™ 77.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007 3.48
2 Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial. BMJ 2003 2.71
3 The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 2006 2.42
4 A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 2013 2.32
5 Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol 2009 2.21
6 Frontotemporal dementia in elderly individuals. Arch Neurol 2012 2.21
7 Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004 2.06
8 Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am J Psychiatry 2004 1.82
9 Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008 1.74
10 Education, the brain and dementia: neuroprotection or compensation? Brain 2010 1.68
11 Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study. Br J Psychiatry 2011 1.58
12 Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. Neuroimage 2004 1.53
13 Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004 1.33
14 Early cognitive change in the general population: how do different definitions work? J Am Geriatr Soc 2007 1.32
15 Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003 1.27
16 Effects of hypertension on attention, memory, and executive function in older adults. Health Psychol 2003 1.23
17 Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol 2010 1.19
18 Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005 1.16
19 Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005 1.11
20 Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009 1.09
21 Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis 2006 1.06
22 Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am J Geriatr Psychiatry 2006 1.05
23 Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. Am J Geriatr Psychiatry 2010 1.02
24 Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord 2003 1.01
25 Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. Br J Psychiatry 2012 1.00
26 Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry 2006 0.99
27 Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 2005 0.97
28 Mild cognitive impairment in the older population: Who is missed and does it matter? Int J Geriatr Psychiatry 2008 0.96
29 Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease. J Neurochem 2012 0.94
30 APOA1 polymorphism influences risk for early-onset nonfamiliar AD. Ann Neurol 2005 0.94
31 Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 2006 0.93
32 Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage 2008 0.93
33 A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry 2005 0.93
34 What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003 0.93
35 A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr 2008 0.93
36 Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002 0.93
37 Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004 0.92
38 Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet 2005 0.92
39 The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004 0.92
40 Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res 2005 0.92
41 Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2007 0.91
42 Pathophysiology of synuclein aggregation in Lewy body disease. Mech Ageing Dev 2005 0.91
43 Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT. J Neurol 2007 0.87
44 Dementia with Lewy bodies. Med Clin North Am 2002 0.87
45 Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. J Neuropathol Exp Neurol 2013 0.86
46 Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 2005 0.85
47 The assessment of cognition in visually impaired older adults. Age Ageing 2012 0.85
48 Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. J Alzheimers Dis 2012 0.85
49 Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 2003 0.85
50 Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. Arch Neurol 2012 0.85
51 Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review. BMJ Open 2013 0.85
52 Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. Int J Neuropsychopharmacol 2006 0.83
53 Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2007 0.83
54 Impact of less common and "disregarded" neurodegenerative pathologies on dementia burden in a population-based cohort. J Alzheimers Dis 2012 0.82
55 Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies. Int Psychogeriatr 2013 0.82
56 In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage 2006 0.81
57 Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiol Aging 2006 0.81
58 Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies. Am J Geriatr Psychiatry 2010 0.81
59 Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop? Int J Geriatr Psychiatry 2006 0.80
60 Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis. J Geriatr Psychiatry Neurol 2009 0.80
61 Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. J Cereb Blood Flow Metab 2013 0.80
62 Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study. Am J Geriatr Psychiatry 2013 0.79
63 Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord 2003 0.79
64 Plasma homocysteine and cognitive decline in older hypertensive subjects. Int Psychogeriatr 2011 0.79
65 Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 2007 0.79
66 Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry 2005 0.79
67 Neuropathological profile of mild cognitive impairment from a population perspective. Alzheimer Dis Assoc Disord 2012 0.79
68 Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. J Neural Transm (Vienna) 2013 0.76
69 Distinct cognitive phenotypes in Alzheimer's disease in older people. Int Psychogeriatr 2013 0.76
70 Elderly individuals with FTLD. JAMA Neurol 2013 0.75
71 Old age psychiatry. Br J Psychiatry 2002 0.75
72 Levodopa use and sleep in patients with dementia with Lewy bodies. Mov Disord 2009 0.75